GR3004267T3 - - Google Patents

Info

Publication number
GR3004267T3
GR3004267T3 GR920400622T GR920400622T GR3004267T3 GR 3004267 T3 GR3004267 T3 GR 3004267T3 GR 920400622 T GR920400622 T GR 920400622T GR 920400622 T GR920400622 T GR 920400622T GR 3004267 T3 GR3004267 T3 GR 3004267T3
Authority
GR
Greece
Prior art keywords
alkyl
alkyleneimino
hydroxyalkyl
aralkyl
acetyl
Prior art date
Application number
GR920400622T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3004267T3 publication Critical patent/GR3004267T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/08—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Cosmetics (AREA)
GR920400622T 1988-08-16 1992-04-02 GR3004267T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888819493A GB8819493D0 (en) 1988-08-16 1988-08-16 2-amino-4-morpholino-6-propyl-1 3 5-triazines

Publications (1)

Publication Number Publication Date
GR3004267T3 true GR3004267T3 (el) 1993-03-31

Family

ID=10642235

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920400622T GR3004267T3 (el) 1988-08-16 1992-04-02

Country Status (28)

Country Link
US (1) US4956367A (el)
EP (1) EP0356413B1 (el)
JP (1) JPH02108675A (el)
KR (1) KR0136108B1 (el)
AT (1) ATE72241T1 (el)
AU (1) AU614247B2 (el)
CA (1) CA1317944C (el)
CY (1) CY1709A (el)
DE (1) DE68900794D1 (el)
DK (1) DK171698B1 (el)
ES (1) ES2038849T3 (el)
FI (1) FI102065B (el)
GB (1) GB8819493D0 (el)
GR (1) GR3004267T3 (el)
HK (1) HK95693A (el)
HU (1) HUT58087A (el)
IE (1) IE61205B1 (el)
IL (1) IL91243A (el)
LT (1) LT3601B (el)
MY (1) MY105008A (el)
NO (1) NO179206C (el)
NZ (1) NZ230290A (el)
PL (2) PL161591B1 (el)
PT (1) PT91438B (el)
RU (3) RU1806142C (el)
SG (1) SG27893G (el)
UA (1) UA11064A (el)
ZA (1) ZA896222B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9024617D0 (en) * 1989-12-05 1991-01-02 Ici Plc Heterocyclic compounds
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
IT1240690B (it) * 1990-04-30 1993-12-17 Ciba Geigy Ag Composti piperdin-triazinici atti all'impiego come stabilizzanti per materiali organici
GB9116039D0 (en) * 1991-07-25 1991-09-11 Ucb Sa Substituted cyclopropylamino-1,3,5-triazines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549757A (en) * 1968-03-27 1970-12-22 Shell Oil Co Use of 2-morpholino - 4 - amino-6-substituted-s-triazines for inducing depressant effects in animals
JPS4969688A (el) * 1972-11-02 1974-07-05
FR2262512A1 (en) * 1974-03-01 1975-09-26 Synthelabo 2,4,6-Tri-substd. -1,3,5-triazines - with analgesic and psychotropic activity

Also Published As

Publication number Publication date
DK398189D0 (da) 1989-08-14
IL91243A0 (en) 1990-03-19
DE68900794D1 (en) 1992-03-12
RU1806142C (ru) 1993-03-30
FI893714A (fi) 1990-02-17
SG27893G (en) 1993-06-25
EP0356413A1 (fr) 1990-02-28
US4956367A (en) 1990-09-11
RU1838312C (ru) 1993-08-30
PT91438A (pt) 1990-03-08
NO893279D0 (no) 1989-08-15
FI893714A0 (fi) 1989-08-07
PT91438B (pt) 1995-05-04
HUT58087A (en) 1992-01-28
FI102065B1 (fi) 1998-10-15
MY105008A (en) 1994-07-30
NO893279L (no) 1990-02-19
AU3991789A (en) 1990-04-05
KR0136108B1 (ko) 1998-04-25
LT3601B (en) 1995-12-27
CA1317944C (en) 1993-05-18
GB8819493D0 (en) 1988-09-21
EP0356413B1 (fr) 1992-01-29
NO179206C (no) 1996-08-28
ZA896222B (en) 1990-05-30
PL161591B1 (pl) 1993-07-30
ES2038849T3 (es) 1993-08-01
RU1822403C (ru) 1993-06-15
AU614247B2 (en) 1991-08-22
IL91243A (en) 1995-05-26
UA11064A (uk) 1996-12-25
IE892619L (en) 1990-02-16
LTIP829A (en) 1995-02-27
CY1709A (en) 1994-01-14
NZ230290A (en) 1991-10-25
NO179206B (no) 1996-05-20
DK398189A (da) 1990-02-17
DK171698B1 (da) 1997-03-24
IE61205B1 (en) 1994-10-19
PL161161B1 (pl) 1993-05-31
HK95693A (en) 1993-09-24
KR900003165A (ko) 1990-03-23
FI102065B (fi) 1998-10-15
ATE72241T1 (de) 1992-02-15
JPH02108675A (ja) 1990-04-20

Similar Documents

Publication Publication Date Title
DE59003587D1 (de) Diarylacetylene, ihre Herstellung und Verwendung.
ATE188965T1 (de) Neue pyrazincarboxamidderivate, ihre herstellung und ihre verwendung in arzneimitteln
ZA895468B (en) Stable free radical containing contrast media
AU3559193A (en) New 3',5'-di-tert-butyl-4'-hydroxy flavones, process for the preparation thereof and pharmaceutical compositions containing them
NO902800D0 (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
IL91244A0 (en) Pharmaceutical compositions containing 2-amino-4-morpholino-6-propyl-1,3,5-triazines
GR3002051T3 (en) 3-oxadiazolyl and 3-carboxylic-acid beta-carboline derivatives, their preparation and their use as medicaments
DE68900794D1 (en) 2-amino-4-morpholino-6-propyl-1,3,5-triazine.
ES2032501T3 (es) Un procedimiento de preparacion de derivados de urileno-2,4,6-triamino-3-oxido.
GR3017916T3 (en) 3,4-Disubstituted phenyl-heterocycles and their use.
IL90043A0 (en) Sulfonanilides,their preparation and pharmaceutical compositions containing them
IL98428A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
HUT70761A (en) Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
DE68922596T2 (de) 3-(3-Ethyl-1,2,4-oxadiazol-5-yl)-1-azabicycloheptan, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen.
IL95384A0 (en) 1,3-oxazines,their preparation and pharmaceutical compositions containing them